Latin America (Brazil, Argentina, Chile, Mexico, Colombia, Venezuela) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant) Report

Latin America (Brazil, Argentina, Chile, Mexico, Colombia, Venezuela) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant) Analysis And Segment Forecasts To 2020

  • Report ID: 978-1-68038-145-0
  • Number of Pages: 96
  • Format: Electronic (PDF)

Table of Contents

Chapter 1. Executive Summary
                  1.1. Latin America Insulin - Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Latin America Insulin Industry Outlook
                  2.1. Market Segmentation
                  2.2. Market Size and Growth Prospects
                  2.3. Latin America Insulin Market Dynamics
                       2.3.1. Market Driver Analysis
                       2.3.2. Market Restraint Analysis
                  2.4. Key Opportunities Prioritized
                  2.5. Industry Analysis - Porter's
                  2.6. Latin America Insulin - Company Market Share Analysis
                  2.7. Latin America Insulin Market PESTEL Analysis, 2012
                  2.8. Latin America Insulin - Pipeline Overview
Chapter 3. Latin America Insulin Product Outlook
                  3.1. Rapid Acting Analog
                       3.1.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                  3.2. Short Acting Insulin
                       3.2.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                  3.3. Intermediate Acting Insulin
                       3.3.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                  3.4. Long Acting Analog
                       3.4.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                  3.5. Pre-Mixed
                       3.5.1.Pre-Mixed Insulin Market Estimates and Forecasts
                           3.5.1.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                       3.5.2.Pre-Mixed Analog Market Estimates and Forecasts
                           3.5.2.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
Chapter 4. Latin America Insulin Segment Outlook
                  4.1. Insulin Analogs
                       4.1.1.Insulin Analogs Market Estimates and Forecasts
                  4.2. Human Recombinant Insulin
                       4.2.1. Human Recombinant Insulin Market Estimates and Forecasts
Chapter 5. Latin America Insulin Application Outlook
                  5.1. Type I and Other Diabetes
                       5.1.1. Type I and Other Diabetes Market Estimates and Forecasts
                  5.2. Type II Diabetes
                       5.2.1. Type II Diabetes Market Estimates and Forecasts
Chapter 6. Insulin Regional Outlook
                  6.1. Brazil
                       6.1.1. Brazil Insulin Market, by Products
                       6.1.2. Brazil Insulin Market, by Applications (only revenue)
                       6.1.3. Brazil Insulin Market, by Source
                  6.2. Argentina
                       6.2.1. Argentina Insulin Market, by Products
                       6.2.2. Argentina Insulin Market, by Applications (only revenue)
                       6.2.3. Argentina Insulin Market, by Source
                  6.3. Chile
                       6.3.1. Chile Insulin Market, by Products
                       6.3.2. Chile Insulin Market, by Applications (only revenue)
                       6.3.3. Chile Insulin Market, by Source
                  6.4. Mexico
                       6.4.1. Mexico Insulin Market, by Products
                       6.4.2. Mexico Insulin Market, by Applications (only revenue)
                       6.4.3. Mexico Insulin Market, by Source
                  6.5. Colombia
                       6.5.1. Colombia Insulin Market, by Products
                       6.5.2. Colombia Insulin Market, by Applications (only revenue)
                       6.5.3. Colombia Insulin Market, by Source
                  6.6. Venezuela
                       6.6.1. Venezuela Insulin Market, by Products
                       6.6.2. Venezuela Insulin Market, by Applications (only revenue)
                       6.6.3. Venezuela Insulin Market, by Source
                  6.7. Peru
                       6.7.1. Peru Insulin Market, by Products
                       6.7.2. Peru Insulin Market, by Applications (only revenue)
                       6.7.3. Peru Insulin Market, by Source
                  6.8. Rest of Latin America
                       6.8.1. Rest of Latin America Insulin Market, by Products
                       6.8.2. Rest of Latin America Insulin Market, by Applications (only revenue)
                       6.8.3. Rest of Latin America Insulin Market, by Source
Companies analyzed in competitive landscape
                  1. Novo Nordisk
                  2. Sanofi
                  3. Eli Lilly
                  4. Bristol-Myers Squibb
                  5. Novartis
                  6. Takeda Pharmaceuticals
                  7. Boehringer Ingelheim
                  8. Biocon
                  9. Dongbao Enterprise Group Co., Ltd.
                  10. Merck KGaA
                  11. Oramed Pharmaceuticals Inc.
                  12. Halozyme Therapeutics
                  13. Wanbang Biopharma
                  14. Xinbai Pharmaceutical
                  15. Gan & Lee Pharmaceutical
                  16. Sandoz
                  17. Amega Biotech
                  18. Biosidus
                  19. Sinergium Biotech
                  20. Probiomed
                  21. EMS Farma.


List of Tables

1. Latin America Insulin - Industry summary & Critical Success Factors (CSFs)
2. Latin America Insulin Market, by Countries, 2012 - 2020 (USD Million)
3. Latin America Insulin Market, by Products, 2012 - 2020 (USD Million)
4. Latin America Insulin Market, by Products, 2012 - 2020 (‘000 Units)
5. Latin America Insulin Market, by Applications, 2012 - 2020 (USD Million)
6. Latin America Insulin Market, by Source Types, 2012 - 2020 (USD Million)
7. Latin America Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
8. Brazil Insulin Market, by Products, 2012 - 2020 (USD Million)
9. Brazil Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
10. Brazil Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
11. Brazil Insulin Market, by Product Types, 2012 - 2020 ('000 units)
12. Brazil Insulin Market, by Source Types, 2012 - 2020 (USD million)
13. Brazil Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
14. Brazil Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
15. Argentina Insulin Market, by Products, 2012 - 2020 (USD Million)
16. Argentina Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
17. Argentina Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
18. Argentina Insulin Market, by Product Types, 2012 - 2020 ('000 units)
19. Argentina Insulin Market, by Source Types, 2012 - 2020 (USD million)
20. Argentina Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
21. Argentina Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
22. Chile Insulin Market, by Products, 2012 - 2020 (USD Million)
23. Chile Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
24. Chile Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
25. Chile Insulin Market, by Product Types, 2012 - 2020 ('000 units)
26. Chile Insulin Market, by Source Types, 2012 - 2020 (USD million)
27. Chile Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
28. Chile Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
29. Mexico Insulin Market, by Products, 2012 - 2020 (USD Million)
30. Mexico Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
31. Mexico Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
32. Mexico Insulin Market, by Product Types, 2012 - 2020 ('000 units)
33. Mexico Insulin Market, by Source Types, 2012 - 2020 (USD million)
34. Mexico Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
35. Mexico Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
36. Colombia Insulin Market, by Products, 2012 - 2020 (USD Million)
37. Colombia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
38. Colombia Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
39. Colombia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
40. Colombia Insulin Market, by Source Types, 2012 - 2020 (USD million)
41. Colombia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
42. Colombia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
43. Venezuela Insulin Market, by Products, 2012 - 2020 (USD Million)
44. Venezuela Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
45. Venezuela Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
46. Venezuela Insulin Market, by Product Types, 2012 - 2020 ('000 units)
47. Venezuela Insulin Market, by Source Types, 2012 - 2020 (USD million)
48. Venezuela Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
49. Venezuela Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
50. Peru Insulin Market, by Products, 2012 - 2020 (USD Million)
51. Peru Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
52. Peru Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
53. Peru Insulin Market, by Product Types, 2012 - 2020 ('000 units)
54. Peru Insulin Market, by Source Types, 2012 - 2020 (USD million)
55. Peru Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
56. Peru Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
57. Rest of Latin America Insulin Market, by Products, 2012 - 2020 (USD Million)
58. Rest of Latin America Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
59. Rest of Latin America Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
60. Rest of Latin America Insulin Market, by Product Types, 2012 - 2020 ('000 units)
61. Rest of Latin America Insulin Market, by Source Types, 2012 - 2020 (USD million)
62. Rest of Latin America Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
63. Rest of Latin America Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)


List of Figures

1. Latin America Insulin Market Segmentation
2. Latin America Insulin Market Revenue, 2012 - 2020
3. Latin America Insulin Market Dynamics
4. Latin America Insulin Company Market Share Analysis, 2012
5. Key Opportunities Prioritized
6. Industry Analysis - Porter's
7. Latin America Insulin PESTEL Analysis, 2012
8. Latin America Insulin market - company market share analysis, 2013 (%)
9. Latin America insulin market, by product type, 2012 - 2020
10. Latin America insulin market, by source types, 2012 - 2020
11. Latin America insulin market, by applications, 2012 - 2020

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon